Related Experiment Video
Updated: Jun 8, 2025

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.5K
Flow Dynamic Factors Correlated With Device-Related Thrombosis After Left Atrial Appendage Occlusion
Brennan J Vogl1, Emily Vitale1, Sunyoung Ahn1
1Department of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.
JACC. Advances
|November 4, 2024
Summary
Device-related thrombosis (DRT) after left atrial appendage occlusion (LAAO) is a risk. Lower wall shear stress and higher oscillatory shear index predict DRT, suggesting flow dynamics can guide risk stratification.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Medical Imaging
Background:
- Device-related thrombosis (DRT) complicates up to 4% of left atrial appendage occlusion (LAAO) procedures.
- The exact causes, predictors, and optimal treatments for DRT remain unclear, necessitating further research.
Purpose of the Study:
- To investigate the correlation between hemodynamic factors and the occurrence of DRT following LAAO.
- To identify specific flow dynamics that may predict DRT risk in patients undergoing LAAO.
Main Methods:
- Utilized a multicenter registry of patients who underwent LAAO with pre- and post-procedure CT imaging.
- Created patient-specific 3D models of the left atrium for finite element and computational fluid dynamics (CFD) simulations.
- Quantified hemodynamic parameters: time-averaged wall shear stress, oscillatory shear index, and endothelial cell activation potential.
Main Results:
- Compared 19 patients with DRT to 19 without, finding larger left atrium volumes and mitral valve areas in the DRT group.
- Patients with DRT exhibited significantly lower time-averaged wall shear stress and higher oscillatory shear index and endothelial cell activation potential (P < 0.001).
- In-vivo thrombus locations correlated well with CFD-derived flow dynamic parameters.
Conclusions:
- Hemodynamic parameters derived from CFD simulations show potential for predicting DRT risk after LAAO.
- Further large-scale studies with long-term follow-up are required to validate CFD's role in risk stratification for LAAO patients.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Clot Retraction and Fibrinolysis
4.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.2K
Disorders of Hemostasis
716
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716

